In the context of MGMT, the epigenetic regulation of gene expression have received a lot of attention in GB research: because methylation of the MGMT gene promoter is expected to reduce gene expression, the increased levels of MGMT promoter methylation are considered prognostic of the cancer responsiveness to treatment with cytotoxic cancer therapy48,49. The gene discussed is MGMT; the disease is cancer.